A new device for quickly identifying bloodstream infections from blood samples
Commercialization Readiness Pilot (CRP) program support for: An Integrated Device for identification of bloodstream infections directly from blood
This study is testing a new, quick blood test that can find and identify infections in your bloodstream in just three hours, helping doctors give you the right treatment faster, even if you've already had antibiotics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Helixbind, INC. NIH-funded |
| Lab location | 1 site (Boxborough, UNITED STATES) |
| Project ID | NIH-11026560 on NIH RePORTER |
What this research studies
This research focuses on developing a fully automated test called RaPID/BSI that can identify and characterize bloodstream infections (BSIs) directly from blood samples in about three hours, significantly faster than current methods that take 1-3 days. The device is designed to work without the need for cultures and can detect a wide range of bacterial and fungal pathogens, even in patients who have received antimicrobial treatment. By providing rapid and accurate results, this technology aims to improve patient outcomes and reduce hospitalization times. The test is suitable for use throughout hospitals, making it accessible for timely diagnosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suspected of having bloodstream infections who require timely diagnosis and treatment.
Not a fit: Patients who are not suspected of having bloodstream infections or those who are not hospitalized may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster diagnosis and treatment of bloodstream infections, potentially saving lives and reducing hospital stays.
How similar studies have performed: Other research has shown promise in developing rapid diagnostic tests for infections, but this specific approach with the RaPID/BSI device is novel.
Where this research is happening
Boxborough, UNITED STATES
- Helixbind, INC. — Boxborough, United States (Active)
Researchers
- Principal investigator: Singer, Alon — Helixbind, INC.
- Study coordinator: Singer, Alon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.